Article
Cancer Metabostemness and Metabolic Reprogramming via P2X7 Receptor
14 Jul 2021
Abstract excerpt
The heterogeneity of tumor cell mass and the plasticity of cancer cell phenotypes in solid tumors allow for the insurgence of resistant and metastatic cells, responsible for cancer patients' clinical management's main challenges. Among several factors that are responsible for increased cancer aggression, metabolic reprogramming is recently emerging as an ultimate cancer hallmark, as it is central for cancer cell...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
